Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The role of the HIV-1 fusion glycoprotein gp41 in immunosuppression
EF 2023-24
Résumé
Human immunodeficiency virus-1 (HIV-1), like many other retroviruses, has the capability of suppressing the immune system through its envelope proteins. HIV-1 has been documented to use a specific fusion envelope protein named gp41 to inhibit immune system activation against its viral particles. This is achieved through a conserved immunosuppressive region (ISR) found in many retroviral membrane proteins. Although previous studies have already highlighted the immunosuppressive effects of synthetic gp41 peptide on immune cells, the putative receptor has yet to be identified. Thus, we propose to use biochemical and structural approaches to elucidate the unidentified receptor, and we hypothesize that the ISR of HIV-1 gp41 binds to surface receptor(s) on immune cells to enhance immunosuppressive cytokine production. To accomplish this, we will perform crosslinking mass spectroscopy analysis on purified gp41 bound to its surface receptor(s), and candidate receptors will be identified. To examine the functional effects of binding viral fusion proteins to immune cells, we will quantify production of different cytokines using multiplex arrays and ELISA. We expect ISR-containing proteins to target a common immune cell type and receptor to trigger immunosuppression. The proposed research is significant because it is the first study to characterize the immunosuppressive phenomenon of HIV-1 using structure-function studies. Identification of specific host cell receptors that are targeted by HIV-1 gp41 lays the groundwork for further research into signal transduction pathways involved, and it provides guidance into the development of effective HIV vaccines and antivirals to recover host immune system function.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506574
Name
Yu Manus
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of the HIV-1 fusion glycoprotein gp41 in immunosuppression
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cross-Linking Mass Spectrometry; Gp41; Hiv-1; Immunology; Immunosuppression; Pbmc; Protein Structure; Viral Disease; Virology
Abstract
Human immunodeficiency virus-1 (HIV-1), like many other retroviruses, has the capability of suppressing the immune system through its envelope proteins. HIV-1 has been documented to use a specific fusion envelope protein named gp41 to inhibit immune system activation against its viral particles. This is achieved through a conserved immunosuppressive region (ISR) found in many retroviral membrane proteins. Although previous studies have already highlighted the immunosuppressive effects of synthetic gp41 peptide on immune cells, the putative receptor has yet to be identified. Thus, we propose to use biochemical and structural approaches to elucidate the unidentified receptor, and we hypothesize that the ISR of HIV-1 gp41 binds to surface receptor(s) on immune cells to enhance immunosuppressive cytokine production. To accomplish this, we will perform crosslinking mass spectroscopy analysis on purified gp41 bound to its surface receptor(s), and candidate receptors will be identified. To examine the functional effects of binding viral fusion proteins to immune cells, we will quantify production of different cytokines using multiplex arrays and ELISA. We expect ISR-containing proteins to target a common immune cell type and receptor to trigger immunosuppression. The proposed research is significant because it is the first study to characterize the immunosuppressive phenomenon of HIV-1 using structure-function studies. Identification of specific host cell receptors that are targeted by HIV-1 gp41 lays the groundwork for further research into signal transduction pathways involved, and it provides guidance into the development of effective HIV vaccines and antivirals to recover host immune system function.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yu, Manus
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~